Cytotoxic T lymphocyte response to peptide vaccination predicts survival in stage III colorectal cancer

We previously reported a phase I clinical trial of a peptide vaccine ring finger protein 43 (RNF43) and 34‐kDa translocase of the outer mitochondrial membrane (TOMM34) combined with uracil‐tegafur (UFT)/LV for patients with metastatic colorectal cancer (CRC), and demonstrated the safety and immunolo...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Sci
Huvudupphovsmän: Kawamura, Junichiro, Sugiura, Fumiaki, Sukegawa, Yasushi, Yoshioka, Yasumasa, Hida, Jin‐ichi, Hazama, Shoichi, Okuno, Kiyotaka
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2018
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5980387/
https://ncbi.nlm.nih.gov/pubmed/29473265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13547
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk